HIV-1 cores retain their integrity until minutes before uncoating in the nucleus.
HIV-1
capsid
core integrity
nuclear import
uncoating
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
09 03 2021
09 03 2021
Historique:
entrez:
2
3
2021
pubmed:
3
3
2021
medline:
18
8
2021
Statut:
ppublish
Résumé
We recently reported that HIV-1 cores that retained >94% of their capsid (CA) protein entered the nucleus and disassembled (uncoated) near their integration site <1.5 h before integration. However, whether the nuclear capsids lost their integrity by rupturing or a small loss of CA before capsid disassembly was unclear. Here, we utilized a previously reported vector in which green fluorescent protein is inserted in HIV-1 Gag (iGFP); proteolytic processing efficiently releases GFP, some of which remains trapped inside capsids and serves as a fluid phase content marker that is released when the capsids lose their integrity. We found that nuclear capsids retained their integrity until shortly before integration and lost their GFP content marker ∼1 to 3 min before loss of capsid-associated mRuby-tagged cleavage and polyadenylation specificity factor 6 (mRuby-CPSF6). In contrast, loss of GFP fused to CA and mRuby-CPSF6 occurred simultaneously, indicating that viral cores retain their integrity until just minutes before uncoating. Our results indicate that HIV-1 evolved to retain its capsid integrity and maintain a separation between macromolecules in the viral core and the nuclear environment until uncoating occurs just before integration. These observations imply that intact HIV-1 capsids are imported through nuclear pores; that reverse transcription occurs in an intact capsid; and that interactions between the preintegration complex and LEDGF/p75, and possibly other host factors that facilitate integration, must occur during the short time period between loss of capsid integrity and integration.
Identifiants
pubmed: 33649225
pii: 2019467118
doi: 10.1073/pnas.2019467118
pmc: PMC7958386
pii:
doi:
Substances chimiques
gag Gene Products, Human Immunodeficiency Virus
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2021 the Author(s). Published by PNAS.
Déclaration de conflit d'intérêts
The authors declare no competing interest.
Références
Elife. 2014 Dec 17;3:e04114
pubmed: 25517934
J Virol. 2007 Nov;81(22):12596-607
pubmed: 17728233
J Virol. 2017 May 26;91(12):
pubmed: 28381579
J Biol Chem. 2004 Dec 31;279(53):55570-7
pubmed: 15475359
J Virol. 2010 Jan;84(1):397-406
pubmed: 19846519
Cell. 2016 Mar 10;164(6):1162-1171
pubmed: 26967283
Nature. 2013 May 30;497(7451):643-6
pubmed: 23719463
J Biol Chem. 2000 Jun 9;275(23):17556-60
pubmed: 10748019
Retrovirology. 2006 Jan 12;3:4
pubmed: 16409631
J Virol. 2020 May 18;94(11):
pubmed: 32238582
Nat Rev Microbiol. 2015 Aug;13(8):471-83
pubmed: 26179359
Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):E7169-E7178
pubmed: 28784755
Retrovirology. 2013 Jul 09;10:70
pubmed: 23835323
J Vis Exp. 2011 Nov 08;(57):
pubmed: 22105356
Retrovirology. 2010 Nov 17;7:96
pubmed: 21083892
EMBO J. 2003 Apr 1;22(7):1707-15
pubmed: 12660176
Rev Med Virol. 2009 Nov;19(6):324-37
pubmed: 19750561
J Virol. 2002 Jun;76(11):5667-77
pubmed: 11991995
Mol Med. 2004 Jan-Jun;10(1-6):1-5
pubmed: 15502876
Cell Host Microbe. 2018 Apr 11;23(4):536-548.e6
pubmed: 29649444
Viruses. 2018 Nov 15;10(11):
pubmed: 30445742
Cell Host Microbe. 2010 Mar 18;7(3):221-33
pubmed: 20227665
Science. 2020 Oct 9;370(6513):
pubmed: 33033190
J Virol. 2003 Aug;77(15):8196-206
pubmed: 12857888
J Virol. 2016 May 27;90(12):5808-5823
pubmed: 27076642
Nat Commun. 2020 Jul 14;11(1):3505
pubmed: 32665593
AIDS Rev. 2004 Oct-Dec;6(4):199-207
pubmed: 15700618
J Biol Chem. 2003 Jan 3;278(1):372-81
pubmed: 12407101
PLoS Pathog. 2017 Aug 21;13(8):e1006570
pubmed: 28827840
EMBO J. 2007 Jun 20;26(12):3025-37
pubmed: 17557080
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):E4780-9
pubmed: 24248339
Nature. 2016 Aug 18;536(7616):349-53
pubmed: 27509857
J Virol. 2015 May;89(10):5350-61
pubmed: 25741002
J Biol Chem. 2004 Nov 19;279(47):48883-92
pubmed: 15371438
Cell. 2007 Oct 5;131(1):70-9
pubmed: 17923088
Proc Natl Acad Sci U S A. 2020 Mar 10;117(10):5486-5493
pubmed: 32094182
J Virol. 2019 Mar 5;93(6):
pubmed: 30567984
Cell. 2019 Mar 7;176(6):1502-1515.e10
pubmed: 30799036
Elife. 2018 Jun 07;7:
pubmed: 29877795
Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18625-30
pubmed: 25518861
Nat Med. 2019 Sep;25(9):1377-1384
pubmed: 31501601
Nat Microbiol. 2020 Sep;5(9):1088-1095
pubmed: 32483230
Curr Top Microbiol Immunol. 2003;281:179-208
pubmed: 12932078
PLoS Pathog. 2016 Jun 20;12(6):e1005709
pubmed: 27322072
J Cell Biol. 2002 Nov 11;159(3):441-52
pubmed: 12417576
Science. 2016 Dec 16;354(6318):1434-1437
pubmed: 27980210
PLoS Pathog. 2007 Oct 26;3(10):1502-10
pubmed: 17967060
Science. 2014 Jan 24;343(6169):428-32
pubmed: 24356113
J Virol. 2006 Apr;80(8):3712-20
pubmed: 16571788
J Biol Chem. 2015 Oct 30;290(44):26412-21
pubmed: 26354430
J Virol. 2016 Jul 11;90(15):6918-6935
pubmed: 27307565
Science. 2015 Jul 3;349(6243):99-103
pubmed: 26044298
Curr Biol. 2008 Aug 26;18(16):1192-202
pubmed: 18722123
Retrovirology. 2007 Oct 24;4:77
pubmed: 17956635
Cell Host Microbe. 2018 Sep 12;24(3):392-404.e8
pubmed: 30173955
J Virol. 2001 Apr;75(8):3626-35
pubmed: 11264352
Nat Rev Microbiol. 2007 Mar;5(3):187-96
pubmed: 17304248
J Gene Med. 2001 Nov-Dec;3(6):517-28
pubmed: 11778899
Elife. 2019 Jan 23;8:
pubmed: 30672737